CVS Group (LON:CVSG) Releases Earnings Results

Posted by Geri Gentry on Sep 26th, 2026

CVS Group (LON:CVSG – Get Free Report) announced its quarterly earnings data on Thursday. The company reported GBX 85.60 earnings per share for the quarter, Digital Look Earnings reports. CVS Group had a net margin of 2.43% and a return on equity of 5.91%.

Here are the key takeaways from CVS Group’s conference call:

Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Stock Down 1.1%

Shares of LON:CVSG opened at GBX 1,208 on Friday. The firm has a 50 day simple moving average of GBX 1,287.09 and a 200-day simple moving average of GBX 1,229.43. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,648. The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41. The company has a market capitalization of £821.08 million, a PE ratio of 17.53, a P/E/G ratio of 1.77 and a beta of 1.07.

Wall Street Analysts Forecast Growth

CVSG has been the subject of a number of analyst reports. Jefferies Financial Group reiterated a “hold” rating and set a GBX 1,400 target price on shares of CVS Group in a research note on Friday. Shore Capital Group reaffirmed a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a report on Thursday. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a report on Monday, July 27th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

Read Our Latest Research Report on CVS Group

Insider Activity at CVS Group

In related news, insider David Wilton bought 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The shares were purchased at an average cost of GBX 1,276 per share, with a total value of £19,140. Also, insider Robin Alfonso purchased 768 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, for a total transaction of £9,937.92. Insiders have purchased 3,860 shares of company stock valued at $4,956,696 in the last ninety days. Insiders own 1.48% of the company’s stock.

Key Stories Impacting CVS Group

Here are the key news stories impacting CVS Group this week:

Positive Sentiment: Dividend supported by shareholder returns: CVS Group recommended a final dividend for the year ended June 30, 2026, payable on December 4, providing an income component for investors. CVS Group recommends final dividend
Positive Sentiment: Insider purchase offers a modest confidence signal: Non-executive director Laura Hagan bought 4,128 CVS Group shares. The transaction may reassure investors about management’s view of the company’s valuation, although its financial impact is limited. CVS Group director share purchase
Positive Sentiment: Berenberg maintained a Buy rating and a GBX 2,000 price target, implying substantial upside from the stock’s recent trading level. Berenberg rating update
Neutral Sentiment: Full-year results were released: CVS Group reported GBX 85.60 in earnings per share, alongside a 2.31% net margin and 5.35% return on equity. The figures provide a fresh performance update, but the relatively low profitability metrics may limit enthusiasm without further detail on growth and costs. CVS Group full-year earnings results
Negative Sentiment: Analyst caution remains the main pressure: Shore Capital reaffirmed its Hold rating and GBX 1,400 target, while Jefferies also maintained Hold with the same target. The repeated neutral recommendations suggest limited near-term conviction despite the higher Berenberg target. Shore Capital Hold rating

CVS Group Company Profile

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.